GENIL:BISTGen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. Analysis
Data as of 2026-08-16 - not real-time
TRY 10.93
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi is priced at TRY 10.93, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 19.2%. With RSI at 67.6 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near TRY 8.99 and resistance around TRY 11.83.
Multiples put this in overvalued territory: 47.5 times earnings against the sector's 29.8. Revenue is growing at 41.7% on a 5.1% profit margin. The 0.31% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 42.1%, a beta of 0.11 and a maximum drawdown of 50.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Multiples put this in overvalued territory: 47.5 times earnings against the sector's 29.8. Revenue is growing at 41.7% on a 5.1% profit margin. The 0.31% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 42.1%, a beta of 0.11 and a maximum drawdown of 50.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
GEN ILAC VE SAGL 2026-03-01 tarihli - KAP bildirimleri Bloomberg HT'de!GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 10.02
- MACD momentum is positive
- 30-day price change of +19.2%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 47.5 versus sector average of 29.8
- Trading above the 200-day average of 10.02
- 30-day volatility of 42.1%
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 47.5 versus sector average of 29.8
- Revenue growth of +41.7%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth41.70%
Profit Margin5.07%
P/E Ratio47.5
ROE10.67%
ROA8.65%
Debt/Equity40.79
P/B Ratio3.8
Op. Cash FlowTRY1.5B
Free Cash FlowTRY-4289989120
Industry P/E29.8
Technical Analysis
TrendNeutral
RSI67.6
SupportTRY 8.99
ResistanceTRY 11.83
MA 20TRY 9.72
MA 50TRY 9.27
MA 200TRY 10.02
MACDBullish
VolumeIncreasing
Fear & Greed Index95.98
Valuation
Fair ValueTRY 6.92
GradeOvervalued
TypeGrowth
Dividend Yield0.31%
Risk Assessment
Beta0.11
Volatility42.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.